Popular on Rezul
- $5 - $20 Million in Sales for 2026; $25 - $40 Million for 2027 Projected with NASA Agreements; New MOU Signed to Improve Solar Tech in Space - 1501
- Heritage at South Brunswick Announces Two New Building Releases In Townhome Collection - 683
- OddsTrader Asks: What Are the Chances Your Team Makes the NFL Playoffs? - 675
- Delirious Comedy Club and House of Magic Open 2nd Location at Silver Sevens Hotel & Casino - Vegas-Quality Shows, Old Vegas Prices - 653
- RUNWAY Milestones 1995-2025 Global Influence - 636
- Vancouver Community College Forms Strategic Partnership with PebblePad - 621
- Trusted HVAC Leader Air Heat America Relaunches to Serve Brookhaven, GA, and Surrounding Communities - 552
- Veteran-Owned Dallas Property Management Company Launches - 537
- Discover Heritage at Manalapan - A New Single Family Community - 534
- Conifer Heating and Expert Plumbing Service | Adams Plumbing & Heating - 358
Similar on Rezul
- Assent Unveils Extended Producer Responsibility Packaging Solution to Simplify Compliance with Expanding Packaging Laws
- Assent Uncovers Over 695 Unique PFAS Across Global Supply Chains as Regulations Increase
- NEW power supply release from Kepco Dynatronix - HSP Advanced
- CCHR: Involuntary Commitment Is Eugenics Repackaged as "Mental Health Care"
- Which NFL Teams Can Rebound from Week 1? OddsTrader Breaks Down the Biggest Questions
- CCHR: For Prevention, Families Deserve Truth From NIH Study on Psychiatric Drugs
- Century Fasteners de Mexico Hires Saúl Pedraza Gómez as Regional Sales Manager in Mexico
- How LIB's Temperature & Humidity Chamber & Walk-in Chamber Warranty Delivered Real Uptime
- Revenue Optics Expands Leadership Team with Appointment of Pamela Sims as Strategic Marketing Advisor
- Boston Industrial Solutions Strengthens Leadership in Silicone Printing with Natron® and New Brands: SilTex® and Citrine®
New MOVE3®: NEM® + Fish Oil Omega Combo Study Confirms Fast Efficacy in Pain & Stiffness Treatment in Healthy Adults
Rezul News/10475626
CARTHAGE, Mo. - Rezul -- Stratum Nutrition® and KD Pharma announce their recent partnership to develop a unique joint health formula combining Stratum's NEM® brand eggshell membrane and KD Pharma's marine omega oils. The combination product is being marketed as MOVE3® and sold in softgels via Stratum and KD's global sales forces. Stratum and KD have agreed on a global exclusive to combine NEM® and KD's marine fish oils. A recent study has been published evaluating the combination's joint pain and stiffness treatment after exercise.
The International Journal of Physical Medicine and Rehabilitation (DOI: 10.35248/2329-9096.20.08.551) recently published a randomized, double-blind, placebo-controlled study designed to evaluate whether the combination of NEM® brand eggshell membrane and KD-Pür® brand concentrated omega-3 EPA/DHA from fish oil (MOVE3®) versus placebo would reduce cartilage turnover and alleviate joint pain and/or stiffness immediately following exercise and 12 hours post exercise in 85 healthy men & women (40-75 years) who performed a step exercise regimen (40 to 100 steps per leg) on alternating days for two consecutive weeks.
MOVE3® produced statistically significant reductions in levels of CTX-II, a biomarker of cartilage degradation, versus placebo after 1 and 2 weeks of exercise (-12.9% & -17.7%, respectively). Compared with placebo, MOVE3® supplementation also significantly relieved joint pain immediately after exercise (-28.6%, p=0.049) at 1 week, pain 12 hours after exercise (-46.7%, p=0.035) at 1 week, and stiffness 12 hours after exercise at 1 week (-40%, p= 0.042). Use of a nutraceutical such as MOVE3® is a promising new approach for alleviating joint pain and stiffness associated with exercise.
More on Rezul News
"The body of science supporting exercise and recovery benefits for both Omega-3 and NEM continues to grow, but this study is unique because it demonstrates benefits in healthy people consuming the MOVE3 formulation after they have exercised," said Adam Ismail, Chief Strategy Officer of the KD Pharma Group. "For sports nutrition products, it is important that consumers be able to feel the benefit, and the fact that we saw a significant improvement compared to placebo means the subjects not only felt the impact of MOVE3 but observed the effects in a rapid timeframe."
"Conducting this clinical trial in exercising healthy adults will allow brands to make label claims relating to joint pain and stiffness and even cartilage protection," added Kevin Ruff, Ph.D., MBA, Senior Director of Scientific & Regulatory Affairs for Stratum Nutrition. "This is an additional benefit that MOVE3® provides beyond any other combination product on the market."
Stratum is the global leader in eggshell membrane science and technology for joint health with products in over 20 countries. For more information about NEM® and other ingredients, please visit www.stratumnutrition.com.
###
About Stratum Nutrition
Maintaining its drive and unwavering vision, and refusing to compromise on quality and integrity, is Stratum Nutrition's way of serving the people whose health will benefit from our customers' products down the line. Stratum Nutrition®, a business of ESM Technologies, LLC, sustainably provides world-class nutrition ingredient solutions to product formulators for human and pet health. Stratum offers a portfolio of research-supported, branded ingredients that are progressive, safe and effective, including NEM® brand eggshell membrane, ESC® brand eggshell calcium, Ahiflower® plant-based omegas-3,6,9, Curcumin 95, BioCurc®, NatAxtinTM astaxanthin, as well as oral-cavity probiotics, BLIS K12™ and BLIS M18™. These trusted ingredients are relied upon by consumers globally. Visit www.stratumnutrition.com for more information.
More on Rezul News
The International Journal of Physical Medicine and Rehabilitation (DOI: 10.35248/2329-9096.20.08.551) recently published a randomized, double-blind, placebo-controlled study designed to evaluate whether the combination of NEM® brand eggshell membrane and KD-Pür® brand concentrated omega-3 EPA/DHA from fish oil (MOVE3®) versus placebo would reduce cartilage turnover and alleviate joint pain and/or stiffness immediately following exercise and 12 hours post exercise in 85 healthy men & women (40-75 years) who performed a step exercise regimen (40 to 100 steps per leg) on alternating days for two consecutive weeks.
MOVE3® produced statistically significant reductions in levels of CTX-II, a biomarker of cartilage degradation, versus placebo after 1 and 2 weeks of exercise (-12.9% & -17.7%, respectively). Compared with placebo, MOVE3® supplementation also significantly relieved joint pain immediately after exercise (-28.6%, p=0.049) at 1 week, pain 12 hours after exercise (-46.7%, p=0.035) at 1 week, and stiffness 12 hours after exercise at 1 week (-40%, p= 0.042). Use of a nutraceutical such as MOVE3® is a promising new approach for alleviating joint pain and stiffness associated with exercise.
More on Rezul News
- Premieres of 10th Annual NY Dog Film Festival & 8th Annual NY Cat Film Festival on Sunday, October 26, 2025 to Benefit Animal Lighthouse Rescue
- $20 Price Target in Noble Capital Research Report as Deal is Signed for NFL Yearbook Advertising Across 25 Stadiums for AI Powered Sports Leader $SEGG
- 3E Launches First AI Agent Designed to Respond with Empathy for College Recruitment
- Security Alert: TZNXG Warns Investors About "Fund Recovery" Scams
- Assent Unveils Extended Producer Responsibility Packaging Solution to Simplify Compliance with Expanding Packaging Laws
"The body of science supporting exercise and recovery benefits for both Omega-3 and NEM continues to grow, but this study is unique because it demonstrates benefits in healthy people consuming the MOVE3 formulation after they have exercised," said Adam Ismail, Chief Strategy Officer of the KD Pharma Group. "For sports nutrition products, it is important that consumers be able to feel the benefit, and the fact that we saw a significant improvement compared to placebo means the subjects not only felt the impact of MOVE3 but observed the effects in a rapid timeframe."
"Conducting this clinical trial in exercising healthy adults will allow brands to make label claims relating to joint pain and stiffness and even cartilage protection," added Kevin Ruff, Ph.D., MBA, Senior Director of Scientific & Regulatory Affairs for Stratum Nutrition. "This is an additional benefit that MOVE3® provides beyond any other combination product on the market."
Stratum is the global leader in eggshell membrane science and technology for joint health with products in over 20 countries. For more information about NEM® and other ingredients, please visit www.stratumnutrition.com.
###
About Stratum Nutrition
Maintaining its drive and unwavering vision, and refusing to compromise on quality and integrity, is Stratum Nutrition's way of serving the people whose health will benefit from our customers' products down the line. Stratum Nutrition®, a business of ESM Technologies, LLC, sustainably provides world-class nutrition ingredient solutions to product formulators for human and pet health. Stratum offers a portfolio of research-supported, branded ingredients that are progressive, safe and effective, including NEM® brand eggshell membrane, ESC® brand eggshell calcium, Ahiflower® plant-based omegas-3,6,9, Curcumin 95, BioCurc®, NatAxtinTM astaxanthin, as well as oral-cavity probiotics, BLIS K12™ and BLIS M18™. These trusted ingredients are relied upon by consumers globally. Visit www.stratumnutrition.com for more information.
More on Rezul News
- KatalisCoin: "Too Secure" for Bad Actors - Platform Embraces "Excessive Compliance" Criticism
- Keyanb Exchange Implements Enhanced Security Protocols Amid Industry-Wide Trust Challenges
- TSWHZC Platform Combines Automated Portfolio Management with Proof of Reserves for Brazil Market Entry
- AureaVault Positions Digital Asset Infrastructure for Shifting Monetary Policy Environment
- JQRBT Unveils High-Speed Trading Infrastructure Designed for Growing Institutional Crypto Market
Source: Stratum Nutrition
0 Comments
Latest on Rezul News
- $ONI Listed on MEXC as ONINO Powers Europe's Tokenization Engine Into Public Platform Launch
- AZETHIO Crypto Exchange Whitepaper Reveals MPC-Secured Infrastructure Processing 1.2 Million Transactions Per Second
- CELOXFI Platform Demonstrates Advanced Security Architecture and Regulatory Framework
- Work 365 Launches PV 3.0: The Keystone Power App for Microsoft CSPs
- Local consultant shows small businesses how to turn red tape into real money
- Tour Napa Like a Local: Vines of Napa Valley Wine Passport AKA Vine Pass Unlocks Hidden Gems
- Dental Surgical Center Accepts Sedation Patients with Medicaid for MD, WV, PA and DC
- WhiteHaven Acquires Multifamily Property in Mesa, Arizona
- 2025 Triangle Parade of Homes features 250+ homes throughout Durham, Orange, Chatham & Wake Counties
- Sloan's Lake Dental Launches New Website to Enhance Patient Experience and Access to Modern Dental Care
- Only 3 Weeks Left till the Start of the OpenSSL Conference 2025
- PulteGroup announces new community in Clay County, Murray Farms
- ENTOUCH Completes $50 million Funding Round
- Teaming Agreement with Emtel Energy USA to Advance Thin-Film PV Energy Storage Capabilities; NASA agreements for Solar Space Tech; Ascent Solar $ASTI
- Nebuvex Acknowledges Platform "Too Secure" for Anonymous Traders; Institutional Investors Disagree
- From Tokyo to Berlin: FreeTo.Chat Unites Cultures with the World's First Confession VRX — EmojiStream™
- AZETHIO Launches Multi-Million Dollar User Protection Initiative Following Unprecedented Platform Growth
- Matecrypt Observes South American Cryptocurrency Adoption Surge Amid Economic Shifts
- Assent Uncovers Over 695 Unique PFAS Across Global Supply Chains as Regulations Increase
- Cryptocurrency Quarterly Trading Volume Surpasses $15 Trillion Record High as BrazilNex Acknowledges Industry 'Growing Pains' Amid Market Speculation